Pennsaid generic
Pennsaid is an anti-arthritis drug owned by Horizon. It was first approved for market use on 16 January, 2014. The active ingredient in Pennsaid is diclofenac sodium.
When will Pennsaid generic be available?
As of now, Pennsaid has a total of 19 patents. None of these patents have expired, thus a generic version of Pennsaid is not available yet. Based on the current patent life, the earliest possible date for a Pennsaid generic could be 10 August, 2030.
Pennsaid uses
Pennsaid, which contains diclofenac sodium, is primarily used for treating osteoarthritis. It is applied topically on the affected joint, particularly the knee. Pennsaid can be used alongside other topical medications or oral NSAIDs. It is also beneficial in treating pain.
Pennsaid patent expiration
Pennsaid, an anti-arthritis medication, has a total of 19 drug patents. The last patent related to this drug is expected to expire on 9 August, 2030. Review the details of each patent to understand the patent landscape of Pennsaid. Below are the details of the patent: